Key Moments

Want to know something specific about what's covered?

We've already dissected every moment. Ask and we will deliver (with timestamps).

TL;DR

Danny Yeung scaled three companies to nine figures, including a $200M supplement brand in 18 months, by prioritizing product quality, relentless testing, and a founder's grit.

Key Insights

1

Yeung's company, IM8, achieved a $100M annual revenue run rate in 11 months and a $200M run rate in 18 months, significantly faster than competitors like Huel (22 months to $1.2B acquisition) and AG1 (10 years to $100M).

2

During COVID-19, Yeung's company Prenetics performed 40,000 PCR tests daily, generating over $700 million in revenue in three years and listing on NASDAQ in 2022.

3

IM8 replaced 16 different supplements with a single daily powder, costing $90 per month, compared to an estimated $250-$300 for individual supplements.

4

To ensure product efficacy, IM8 partnered with a scientific advisory board including Dr. Don Musum (Mayo Clinic) and James Green (former NASA chief of science), and conducted clinical trials and third-party testing by Eurofins and NSF.

5

IM8 runs 2,000-3,000 ads live at any given time, testing 500-800 creators weekly, and invests heavily in offline events (200+ held) to build brand authenticity and community.

6

Yeung attributes his entrepreneurial resilience to his early experiences dropping out of high school and working in telemarketing, where he learned to handle rejection and operate with limited information.

Rapid ascent in the supplement market with IM8

Danny Yeung's latest venture, IM8, has achieved remarkable growth, reaching a $100 million annual revenue run rate in just 11 months and a $200 million run rate in 18 months. This pace outstrips established players like Huel, which took 22 months to reach a valuation leading to a $1.2 billion acquisition, and AG1, which took a decade to hit $100 million in revenue. IM8's success is attributed to its innovative product, which consolidates 16 different supplements into a single daily powder, offered at $90 per month, a significant reduction from the estimated $250-$300 cost of purchasing those supplements individually. The company's strategy centers on a superior product, unique branding (a red powder instead of the common green), and aggressive, data-driven marketing.

Leveraging the COVID-19 pandemic for explosive growth

Yeung's previous company, Prenetics, a life sciences and DNA testing firm founded in 2014, was strategically positioned to capitalize on the COVID-19 pandemic. Within two weeks of the pandemic's onset, Prenetics developed and launched a COVID PCR testing kit, quickly becoming Hong Kong's and the UK's leading provider. At its peak, the company was conducting 40,000 PCR tests daily, ultimately performing 28 million tests over three years. This period saw Prenetics generate over $700 million in revenue, with net profits exceeding $100 million. The company's significant role led to its listing on NASDAQ in 2022, making its tests mandatory for all arrivals in Hong Kong.

Navigating market cap collapse and pivoting to supplements

Following the boom of COVID-19 testing, Prenetics experienced a dramatic market cap decline, falling from over $1 billion to approximately $50 million within 18 months. This significant drop highlighted the volatile nature of businesses tied to specific market conditions. During this challenging period, Yeung met David Beckham, who shared frustrations with the overwhelming number of supplements required for a daily routine. This conversation sparked the idea for IM8. Yeung proposed a co-founder role to Beckham, emphasizing that the brand needed to transcend celebrity status and establish its own longevity. This pivot into the highly competitive supplement market, initially met with skepticism from his board due to his lack of direct experience, became the foundation for IM8.

Building a product based on science and consumer needs

Yeung's approach to creating IM8 prioritized scientific validation and consumer experience. He assembled a world-class scientific advisory board, including Dr. Don Musum from Mayo Clinic and James Green, former chief of science at NASA, to help formulate the product. The company also conducted clinical trials and secured third-party testing from Eurofins and NSF, ensuring the product is free from banned substances, a critical factor for athletes. A key focus was also on taste, with Yeung spending a week testing dozens of flavors to ensure palatability, recognizing that even the best product won't succeed if consumers dislike drinking it. This meticulous attention to both scientific backing and user experience is central to IM8's value proposition.

Aggressive marketing and content creation machine

IM8 employs a massive-scale marketing strategy, running 2,000-3,000 ads simultaneously on Meta platforms and testing 500-800 creators weekly. The company leverages a combination of famous ambassadors, affiliate creators, and internal studio production to generate a constant stream of diverse content tailored to different customer personas. This relentless testing and creative output are crucial for maintaining engagement and overcoming creative fatigue. Furthermore, IM8 has hosted over 200 offline events, a strategy Yeung believes is vital for building brand authenticity and community, especially in an age of AI-generated content. These events allow direct interaction with scientific advisors and formulators, reinforcing the brand's commitment to science and transparency.

The genesis of an entrepreneurial mindset: resilience and street smarts

Yeung's entrepreneurial philosophy is deeply rooted in his challenging youth, including dropping out of high school and working as a telemarketer at 15. This experience taught him invaluable lessons in resilience, handling rejection, and operating with limited information. He views his ability to 'figure things out' on the fly as a critical asset. This 'street smart' approach allowed him to secure significant deals, such as the $4 million contract with MGM for hotel furniture, by persistently cold-calling and demonstrating value. The high rejection rate in telemarketing (90-95%) instilled a thick skin, which he applies to investor pitches and business negotiations, viewing each 'no' as a step closer to a 'yes'—a concept echoed by his uncle's strategy of 'putting a price on the word no'.

Founder's duality: balancing delusion and realism

Yeung emphasizes that successful entrepreneurship requires a delicate balance between delusion and realism. Founders must possess the delusional belief to pursue ambitious goals with little evidence, fostering faith and conviction against market or expert advice. However, they must also be capable of switching to hyper-realism to make sound decisions and navigate challenges. He argues that those who are never delusional become employees, while those who are only delusional end up as failed founders. The art lies in knowing when to employ each mode, a skill Yeung demonstrated when pivoting Prenetics' business model post-COVID and when launching IM8 into a crowded supplement market despite his board's initial reservations. This ability to take calculated risks, stemming from a founder's deep stake in the venture, differentiates them from hired CEOs.

Entrepreneurial Success Factors

Practical takeaways from this episode

Do This

Focus on building the best product in the market.
Be deeply involved in all key aspects of the business.
Maintain a balance between delusion (faith in vision) and hyper-realism (data-driven decisions).
Prioritize delivering greater value to customers and partners.
Be persistent and resilient in the face of rejection.
Develop a thick skin and learn to 'price the word no'.

Avoid This

Don't rely solely on celebrity endorsement; ensure the brand lives beyond them.
Don't ignore taste profile; it's crucial for product adoption.
Don't enter new markets like China with the same business model as the US.
Don't be afraid to make drastic cuts when necessary, even if difficult.
Don't mistake a CEO's conservative approach for a founder's necessary risk-taking.
Don't think there are 'hacks' to success; focus on being genuinely better.

Supplement Brand Growth Comparison

Data extracted from this episode

BrandTime to $100M Revenue Run RateAcquisition Value (if applicable)
IM811 monthsN/A (Public Company)
Groom22 months$1.2 billion
Ag110 yearsN/A

IM8 Financials

Data extracted from this episode

MetricValueTimeframe
Revenue Run Rate$100 million11 months
Revenue Run Rate$200 million18 months
Monthly Revenue$20 millionRecent (after 20 months)
Average Order Value (AOV)$230Q1
Customer Acquisition Cost (CAC)$305Q1
Customer Acquisition Cost (CAC)$301Q2 (after doubling marketing spend)
Customer Acquisition Cost (CAC)$239July
Marketing Spend$17 millionQ1
Marketing Spend$33 millionQ2

Common Questions

Danny started telemarketing at 15 selling timeshares, which taught him resilience, street smarts, and how to handle rejection. This foundational experience, coupled with his ability to adapt and learn, paved the way for his later ventures in restaurants, hotel furniture, e-commerce, and life sciences.

Topics

Mentioned in this video

More from My First Million

View all 67 summaries

Ask anything from this episode.

Save it, chat with it, and connect it to Claude or ChatGPT. Get cited answers from the actual content — and build your own knowledge base of every podcast and video you care about.

Get Started Free